Dorman is undervalued, with earnings power projected at $10/share in 2027 and a price target of $160. Q1 results were impacted by peak tariff costs under FIFO accounting, but margin normalization and growth are expected through year-end. Management reaffirmed full-year guidance, anticipating 7-9% sales growth and operating margins exiting 2024 in the high teens.